Two articles in Clinical Cancer Research and International Journal of Cancer by Wei research group and their international collaborators
Synergistic interaction of HOXB13 and CIP2A predispose to aggressive prostate cancer
Are you already on the path of turning your discovery into action? Our pitch-competition is for you!
Sliz E, Sebert S, Würtz P, Kangas AJ, Soininen P, Lehtimäki T, Kähönen M, Viikari J, Männikkö M, Ala-Korpela M, Raitakari OT, Kettunen J.
Professor Lauri Eklund and doctoral student Prateek Singh from the University of Oulu together with their European partners have received nearly 3.8 million euro funding for the H2020-MSCA-ITN project called V.A. Cure. The goal is to provide doctoral education for early-stage researchers in the field of vascular biology, and to uncover the disease causing mechanisms to establish novel therapeutic strategies for vascular anomalies.
Biocenter Oulu Scientific Director, Professor Johanna Myllyharju has been appointed by the Finnish Government as the Chair of The Board of the Academy of Finland.
The research group of Professor Taina Pihlajaniemi has received a 485 000 € grant from Jane and Aatos Erkko Foundation for a project titled “Cell-extra cellular matrix interplay in cancer – New per
Docent Terhi Tapiainen, an Emerging project PI in Biocenter Oulu, has received funding for clinical researchers from The Academy of Finland’s Research Council for Health.
The Academy of Finland’s Research Council for Biosciences and Environment granted funding for two Biocenter Oulu project leaders, Prof. Lloyd Ruddock and Prof. Seppo Vainio. Prof.
Biocenter Oulu PI Tanja Pyhäjärvi´s group participates in a collaborative project B4EST that has been selected for funding by European Commission.
An article entitled “High-throughput screening of prostate cancer risk loci by single nucleotide polymorphisms sequencing” was published online in Nature Communications by Dr.
Biocenter Finland produced a brochure and a video to showcase the technology platforms and BF in general
The paper brochure as well as links to the video (http://www.esitteemme.fi/video/C8F35199) and a digital version of the brochure (
This is an important advance notice for all principal investigators (PIs) planning to participate in the upcoming Biocenter Oulu research project call for 2020-2023.
Two Biocenter Oulu Project Leaders have received Academy of Finland Project Funding: Prof.
A joint article with Myllyharju and Manninen groups from Biocenter Oulu and Prof. Karl Matlin´s group, University of Chicago, USA, was recently published in J Cell Science.
More information here: http://www.oulu.fi/uniogs/dp/hbsdp/call-course-funding
An article on discovery of novel breast cancer risk loci and mechanisms in Cancer Research by Wei research group and their China collaborators
An article entitled “A large-scale, exome-wide association study of Han Chinese women identifies three novel loci predisposing to breast cancer” was recently published in Cancer Research by Dr.
Sigrid Jusélius Foundation 2018 funding decision awarded in total 435 000€ to the following research project leaders (in alphabetical order): Karppinen Peppi, Lehtiö Lari, Myllyharju Johanna, Pihla
University of Oulu allocated doctoral training positions to emerging research themes – within the context of the four strategic focus institutes Biocenter Oulu, Eudaimonia,
A study lead by Uusimaa and Hinttala reveals a new gene required for normal fetal development and severe childhood multiorgan disease
Professor of Pediatric Neurology, Johanna Uusimaa, and Academy Research Fellow, Docent Reetta Hinttala together with their research team and collaborators have described a new, fatal multiorgan dis
Vainio group has published recently an article in J Extracellular vesicles with the title “Exosomes as secondary inductive signals involved in kidney organogenesis” authored by Krause M, Rak-Raszew
BCO project leader Doc. Lauri Eklund is a partner in a consortium receiving 1,1 mill. € from the Academy of Finland Health from Science (TERVA) 2017 funding instrument.
Professor Robert Winqvist and the research team has been awarded a grant of 450 000€ from the Cancer Foundation.